Abstract
Background: Patients with gliomas face significant challenges in daily life due to rapidly progressing neurological and cognitive symptoms. In recent years, there has been increased awareness of the importance of timely referral to specialized palliative care (SPC) for patients with gliomas. This study evaluated referral processes and interdisciplinary services used by patients with gliomas and their caregivers. Methods: Patients with gliomas (World Health Organization [WHO] grade 2–4) treated at Odense University Hospital in Denmark from 2016 to 2020 were retrospectively identified. Data on demographics, treatment, and SPC referrals were collected from medical records and the Danish Palliative Care Database. Descriptive statistics and survival analysis were performed using STATA 17. Results: Among 443 patients, 185 initiated SPC, generally 7 months after the primary diagnosis. Patients with WHO grade 4 gliomas received SPC for a median of 2.5 months before death. All SPC patients had contact with both a palliative care physician and a designated contact nurse; in addition, 63% utilized the services of at least one other multidisciplinary professional, most commonly a physiotherapist. Use of the services of two or more multidisciplinary professionals was most frequent in patients under 50 years old (67%), compared with 39% of patients aged 50 to 70 years and 16% of patients over 70 years. Conclusion: Patients with gliomas are often referred to SPC but typically late in their disease trajectory. The involvement of various SPC professionals underscores a significant demand for interdisciplinary support, which may be underestimated in this study. Younger patients made greater use of SPC services than older patients, indicating an age-dependent need for support from different professionals within the SPC team. Further investigation is needed, particularly in older patients.
References
Addington-Hall, J., & Altmann, D. (2000). Which terminally ill cancer patients in the United Kingdom receive care from community specialist palliative care nurses? Journal of Advanced Nursing, 32(4), 799–806.
Adsersen, M., Thygesen, L. C., Neergaard, M. A., Jensen, A. B., Sjøgren, P., Damkier, A., Clausen, L. M., & Groenvold, M. (2019). Cohabitation status influenced admittance to specialized palliative care for cancer patients: A nationwide study from the Danish Palliative Care Database. Journal of Palliative Medicine, 22(2), 164–172. https://doi.org/10.1089/jpm.2018.0201
Arber, A., Faithfull, S., Plaskota, M., Lucas, C., & de Vries, K. (2010). A study of patients with a primary malignant brain tumour and their carers: Symptoms and access to services. International Journal of Palliative Nursing, 16(1), 24–30. https://doi.org/10.12968/ijpn.2010.16.1.46180
Bakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., & Ahles, T. A. (2009). Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial. JAMA, 302(7), 741–749. https://doi.org/10.1001/jama.2009.1198
Bakitas, M. A., Tosteson, T. D., Li, Z., Lyons, K. D., Hull, J. G., Li, Z., Dionne-Odom, J. N., Frost, J., Dragnev, K. H., Hegel, M. T., Azuero, A., & Ahles, T. A. (2015). Early versus delayed initiation of concurrent palliative oncology care: Patient outcomes in the ENABLE III randomized controlled trial. Journal of Clinical Oncology, 33(13), 1438–1445. https://doi.org/10.1200/jco.2014.58.6362
Boele, F. W., Weimer, J., Zamanipoor Najafabadi, A. H., Murray, L., Given, C. W., Given, B. A., Donovan, H. S., Drappatz, J., Lieberman, F. S., & Sherwood, P. R. (2022). The added value of family caregivers’ level of mastery in predicting survival of glioblastoma patients: A validation study. Cancer Nursing, 45(5), 363–368. https://doi.org/10.1097/ncc.0000000000001027
Boltezar, L., Novakovic, B. J., & Moltara, M. E. (2021). Trends in specialized palliative care referrals at an oncology center from 2007 to 2019. BMC Palliative Care, 20(1), 135. https://doi.org/10.1186/s12904-021-00828-w
Davies, E., & Higginson, I. J. (2004). Better palliative care for older people. World Health Organization.
Dionne-Odom, J. N., Azuero, A., Lyons, K. D., Hull, J. G., Tosteson, T., Li, Z., Li, Z., Frost, J., Dragnev, K. H., Akyar, I., Hegel, M. T., & Bakitas, M. A. (2015). Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: Outcomes from the ENABLE III randomized controlled trial. Journal of Clinical Oncology, 33(13), 1446–1452. https://doi.org/10.1200/jco.2014.58.7824
Gill, S. U. A., Hollegaard, S., & Schønnemann, K. R. (2023). Implementation of early palliative care in an oncologic outpatient clinic—An observational study of the first year. Acta Oncologica, 62(5), 522–527. https://doi.org/10.1080/0284186x.2023.2212410
Golla, H., Ale Ahmad, M., Galushko, M., Hampl, J., Maarouf, M., Schroeter, M., Herrlinger, U., Hellmich, M., & Voltz, R. (2014). Glioblastoma multiforme from diagnosis to death: A prospective, hospital-based cohort pilot feasibility study of patient-reported symptoms and needs. Supportive Care in Cancer, 22(12), 3341–3352. https://doi.org/10.1007/s00520-014-2384-z
Golla, H., Nettekoven, C., Bausewein, C., Tonn, J. C., Thon, N., Feddersen, B., Schnell, O., Böhlke, C., Becker, G., Rolke, R., Clusmann, H., Herrlinger, U., Radbruch, L., Vatter, H., Güresir, E., Stock, S., Müller, D., Civello, D., Papachristou, I.,...Goldbrunner, R. (2020). Effect of early palliative care for patients with glioblastoma (EPCOG): A randomised phase III clinical trial protocol. BMJ Open, 10(1), e034378. https://doi.org/10.1136/bmjopen-2019-034378
Groenvold, M., Adsersen, M., & Hansen, M. B. (2016). Danish Palliative Care Database. Clinical Epidemiology, 8, 637–643. https://doi.org/10.2147/clep.S99468
Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., Fayers, P. M., de Graeff, A., Hammerlid, E., Kaasa, S., Sprangers, M. A., & Bjorner, J. B. (2006). The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care. European Journal of Cancer, 42(1), 55–64. https://doi.org/10.1016/j.ejca.2005.06.022
Hemminger, L. E., Pittman, C. A., Korones, D. N., Serventi, J. N., Ladwig, S., Holloway, R. G., & Mohile, N. A. (2017). Palliative and end-of-life care in glioblastoma: Defining and measuring opportunities to improve care. Neuro-Oncology Practice, 4(3), 182–188. https://doi.org/10.1093/nop/npw022
Johnsen, A. T., Petersen, M. A., Pedersen, L., & Groenvold, M. (2009). Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliative Medicine, 23(6), 491–501. https://doi.org/10.1177/0269216309105400
Jøhnk, C., Laigaard, H. H., Pedersen, A. K., Bauer, E. H., Brandt, F., Bollig, G., & Wolff, D. L. (2022). Time to end-of-life of patients starting specialised palliative care in Denmark: A descriptive register-based cohort study. International Journal of Environmental Research and Public Health, 19(20). https://doi.org/10.3390/ijerph192013017
Kaasa, S. (2013). Interview: Cancer pain management: The last decade and looking forward. Pain Management, 3(6), 431–434. https://doi.org/10.2217/pmt.13.56
Kim, J. Y., Peters, K. B., Herndon, J. E., 2nd, & Affronti, M. L. (2020). Utilizing a palliative care screening tool in patients with glioblastoma. Journal of the Advanced Practitioner in Oncology, 11(7), 684–692. https://doi.org/10.6004/jadpro.2020.11.7.3
Kuchinad, K. E., Strowd, R., Evans, A., Riley, W. A., & Smith, T. J. (2017). End-of-life care for glioblastoma patients at a large academic cancer center. Journal of Neuro-Oncology, 134(1), 75–81. https://doi.org/10.1007/s11060-017-2487-8
Lloyd, A., Kendall, M., Carduff, E., Cavers, D., Kimbell, B., & Murray, S. A. (n.d.). Why do older people get less palliative care than younger people? Primary Palliative Care Research Group, Centre for Population Health Sciences, The Usher Institute, The University of Edinburgh. http://www.cphs.mvm.ed.ac.uk/groups/ppcrg/
Oberndorfer, S., Lindeck-Pozza, E., Lahrmann, H., Struhal, W., Hitzenberger, P., & Grisold, W. (2008). The end-of-life hospital setting in patients with glioblastoma. Journal of Palliative Medicine, 11(1), 26–30. https://doi.org/10.1089/jpm.2007.0137
Ostgathe, C., Gaertner, J., Kotterba, M., Klein, S., Lindena, G., Nauck, F., Radbruch, L., & Voltz, R. (2010). Differential palliative care issues in patients with primary and secondary brain tumours. Supportive Care in Cancer, 18(9), 1157–1163. https://doi.org/10.1007/s00520-009-0735-y
Renovanz, M., Maurer, D., Lahr, H., Weimann, E., Deininger, M., Wirtz, C. R., Ringel, F., Singer, S., & Coburger, J. (2018). Supportive care needs in glioma patients and their caregivers in clinical practice: Results of a multicenter cross-sectional study. Frontiers in Neurology, 9, 763. https://doi.org/10.3389/fneur.2018.00763
Seekatz, B., Lukasczik, M., Löhr, M., Ehrmann, K., Schuler, M., Keßler, A. F., Neuderth, S., Ernestus, R. I., & van Oorschot, B. (2017). Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care. Supportive Care in Cancer, 25(9), 2761–2770. https://doi.org/10.1007/s00520-017-3687-7
Sterckx, W., Coolbrandt, A., Dierckx de Casterlé, B., Van den Heede, K., Decruyenaere, M., Borgenon, S., Mees, A., & Clement, P. (2013). The impact of a high-grade glioma on everyday life: A systematic review from the patient’s and caregiver’s perspective. European Journal of Oncology Nursing, 17(1), 107–117. https://doi.org/10.1016/j.ejon.2012.04.006
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A. A., Gijtenbeek, J., Marosi, C., Vecht, C. J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T.,…National Cancer Institute of Canada Clinical Trials Group. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet. Oncology, 10(5), 459–466. https://doi.org/10.1016/S1470-2045(09)70025-7
Tagami, K., Masukawa, K., Inoue, A., Morita, T., Hiratsuka, Y., Sato, M., Kohata, K., Satake, N., Kizawa, Y., Tsuneto, S., Shima, Y., & Miyashita, M. (2022). Appropriate referral timing to specialized palliative care service: Survey of bereaved families of cancer patients who died in palliative care units. Supportive Care in Cancer, 30(1), 931–940. https://doi.org/10.1007/s00520-021-06493-2
Temel, J. S., Greer, J. A., El-Jawahri, A., Pirl, W. F., Park, E. R., Jackson, V. A., Back, A. L., Kamdar, M., Jacobsen, J., Chittenden, E. H., Rinaldi, S. P., Gallagher, E. R., Eusebio, J. R., Li, Z., Muzikansky, A., & Ryan, D. P. (2017). Effects of early integrated palliative care in patients with lung and GI cancer: A randomized clinical trial. Journal of Clinical Oncology, 35(8), 834–841. https://doi.org/10.1200/jco.2016.70.5046
World Health Organization. (2020). Palliative care. https://www.who.int/news-room/fact-sheets/detail/palliative-care
